Toma Oganezova, Medical Oncologist at Nairi Medical Center, Senior Scientist at Immune Research Institute, Editor-in-Chief at OncoDaily IO, shared CancerWorld’s post on LinkedIn, adding:
“Honored to be featured in CancerWorld Issue #114 (April)
I’m grateful to the CancerWorld team for publishing my article, where I explore the evolving landscape of cancer vaccines.
Once considered a distant goal, cancer vaccines are now re-emerging as a promising pillar of oncology driven by advances in immunotherapy, genomics, and mRNA technologies. From personalized neoantigen approaches to therapeutic vaccine strategies, we are entering a new era where the immune system can be more precisely trained to recognize and target cancer.
At the same time, an important question remains: how do we ensure these innovations move beyond breakthroughs and truly reach patients in clinical practice?
Thank you to everyone contributing to this field and to the broader oncology community pushing these boundaries forward.
Quoting CancerWorld’s post:
“CancerWorld Issue #114 (April) is live!
What does ‘progress’ in oncology really mean?
From conflict zones to overstretched hospitals, oncology is advancing scientifically, but not always reaching the people who need it.
The first cover story focuses on cancer care in conflict settings. As hospitals are damaged, supply chains disrupted, and systems fail, patients with treatable disease are left without options. The OncoCorridor initiative is presented not only as a response to fragmented humanitarian efforts, but as a warning: without coordination progress in oncology cannot reach those who need it most.
The second cover story turns to a different, but equally critical challenge—execution. Isabel Mestres, CEO of City Cancer Challenge (C/Can), brings the focus back to what it takes to make change happen in practice: not in strategy documents, but in real health systems, cities, and hospitals where complexity is constant and implementation determines outcomes.
Beyond the cover stories, this issue explores:
- The risk of clinical detachment in an increasingly AI-driven oncology landscape
- Patient autonomy and ethical decision-making in complex and end-of-life care
- The role of empathy as technology reshapes oncology practice
- 10 years of progress in pancreatic cancer advocacy, alongside persistent challenges in diagnosis and access
- The under-integration of nutrition in cancer care despite strong evidence
- Community-based palliative care and the expansion of support beyond hospitals
- The resurgence of cancer vaccines through advances in immunotherapy, genomics, and mRNA platforms
- Survivorship beyond cure and its long-term physical and emotional impact
- The need to integrate psycho-oncology and psychosocial support into standard oncology care.
Across all of it, one message stands out: Innovation means little if it doesn’t reach patients.
Read the full issue and join the conversation shaping the future of cancer care.”
More posts about CancerWorld.